RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $66,000 | -46.8% | 12,052 | -5.6% | 0.03% | -36.2% |
| Q4 2021 | $124,000 | -7.5% | 12,773 | +70.8% | 0.05% | -20.3% |
| Q3 2021 | $134,000 | -30.2% | 7,478 | -5.0% | 0.06% | -25.3% |
| Q2 2021 | $192,000 | -78.9% | 7,868 | -77.1% | 0.08% | -79.5% |
| Q1 2021 | $911,000 | +255.9% | 34,396 | +1.8% | 0.38% | +263.2% |
| Q4 2020 | $256,000 | +0.4% | 33,793 | -33.6% | 0.11% | -20.9% |
| Q3 2020 | $255,000 | -26.3% | 50,863 | -12.0% | 0.13% | -18.3% |
| Q2 2020 | $346,000 | – | 57,793 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |